/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Delcath Systems Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$9.73 0.0376(3.76%) DCTH at 04 Dec 2025 04:29 PM Medical Devices
Lowest Today 9.3
Highest Today 9.72
Today’s Open 9.35
Prev. Close 9.31
52 Week High 18.23
52 Week Low 8.12
Day’s Range: Low 9.3 High 9.72
52-Week Range: Low 8.12 High 18.23
1 day return -
1 Week return -0.72
1 month return +6.16
3 month return -12.79
6 month return -41.22
1 year return -15.8
3 year return +233.73
5 year return -40.16
10 year return -

Institutional Holdings

Rosalind Advisors, Inc. 9.43

BlackRock Inc 4.91

Vanguard Group Inc 4.60

Vanguard Total Stock Mkt Idx Inv 2.57

Deerfield Management Co 2.32

Citadel Advisors Llc 2.30

iShares Russell 2000 ETF 2.10

Geode Capital Management, LLC 2.01

Vivo Capital, LLC 1.63

Marshall Wace Asset Management Ltd 1.38

State Street Corp 1.35

Morgan Stanley - Brokerage Accounts 1.31

Oberweis Asset Management Inc 1.20

Oberweis Micro-Cap 1.20

Oberweis Micro-Cap Growth 1.20

Amvescap Plc. 0.99

Ikarian Capital, LLC 0.92

Invesco Dorsey Wright SmallCap Momt ETF 0.92

Kennedy Capital Management Inc 0.91

Vanguard Institutional Extnd Mkt Idx Tr 0.88

Cubist Systematic Strategies, LLC 0.88

Fidelity Small Cap Index 0.86

Northern Trust Corp 0.78

Palisades Investment Partners, LLC 0.77

iShares Russell 2000 Growth ETF 0.75

Simplify Propel Opportunities ETF 0.75

Millennium Management LLC 0.71

Propel Bio Management LLC 0.65

Kennedy Micro Cap 0.61

The Informed Momentum Company (formerly EAM Investors) 0.61

Fidelity Extended Market Index 0.45

Vanguard Russell 2000 ETF 0.41

Palisades Small Cap Core 0.31

State St Russell Sm Cap® Indx SL Cl I 0.30

Kennedy Micro Cap Opportunities 0.30

SPDR® S&P Health Care Equipment ETF 0.24

Schwab Small Cap Index 0.22

NT R2000 Index Fund - NL 0.21

iShares Micro-Cap ETF 0.20

Pleiades Small Cap Equity A 0.18

Market Status

Strong Buy: 4

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 328.77 M

PB Ratio 2.9457

PE Ratio 310.3333

Enterprise Value 250.36 M

Total Assets 76.59 M

Volume 518242

Company Financials

Annual Revenue FY23:2165000 2.2M, FY22:2719000 2.7M, FY21:3555000 3.6M, FY20:1646000 1.6M, FY19:1580000 1.6M

Annual Profit FY23:1464000 1.5M, FY22:2033000 2.0M, FY21:2884000 2.9M, FY20:1006000 1.0M, FY19:861000 0.9M

Annual Net worth FY23:-45014000 -45.0M, FY22:-39163000 -39.2M, FY21:-26757000 -26.8M, FY20:-24485000 -24.5M, FY19:-13627000 -13.6M

Quarterly Revenue Q3/2025:20563000 20.6M, Q2/2025:24156000 24.2M, Q1/2025:19784000 19.8M, Q3/2024:9560000 9.6M, Q2/2024:7766000 7.8M

Quarterly Profit Q3/2025:17939000 17.9M, Q2/2025:20838000 20.8M, Q1/2025:16939000 16.9M, Q3/2024:9560000 9.6M, Q2/2024:6247000 6.2M

Quarterly Net worth Q3/2025:830000 0.8M, Q2/2025:2697000 2.7M, Q1/2025:1069000 1.1M, Q3/2024:1864000 1.9M, Q2/2024:-13741000 -13.7M

Fund house & investment objective

Company Information Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. The company was founded in 1987 and is headquartered in New York, New York.

Organisation Medical Devices

Employees 96

Industry Medical Devices

CEO Mr. Gerard J. Michel MBA, MS

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow